Generic name:emicizumab [ EM-a-SIZ-ue-mab ]
Drug class:Miscellaneous coagulation modifiers
What is Hemlibra?
Hemlibra is a monoclonal antibody that functions in place of a natural blood-clotting factor that is missing in people with hemophilia A. Emicizumab works as a "bridge" between other clotting factors to replace missing factor VIII.
Hemlibra is for adults and children with hemophilia A with or without factor VIII inhibitors. Hemlibra is used to help prevent bleeding episodes or make them occur less often.
Hemlibra will not stop a bleeding episode that has already begun.
Warnings
Hemlibra can cause unwanted blood clots when used together with a bypassing agent such as FEIBA. This can damage small blood vessels in your arms and legs, brain, kidneys, lungs, or other organs.
Tell your doctor if you use a bypassing agent or factor VIII. You will most likely need to stop using them the day before you begin using Hemlibra.
If you use Hemlibra and a bypassing agent together, call your doctor at once if you have any of these symptoms: weakness, confusion, stomach or back pain, vomiting, decreased urination, chest pain, trouble breathing, coughing up blood, swelling or redness in your arms or legs, eye pain, or vision problems.
Before taking this medicine
You should not use Hemlibra if you are allergic to emicizumab.
Tell your doctor if you use factor VIII or a bypassi...
